Technavio analysts identified the top three trends of the global spinal biologics market between 2018 and 2022.
Here are the three trends boosting the global spinal biologics market.
1. Escalating strategic alliances. The spinal biologics field will see a lot of merger and acquisition activity, with the goal of increasing products and expanding globally. The report highlights ChoiceSpine acquiring Exactech's spinal assets.
2. Increasing number of lumbar fusion cases. An increasing geriatric population coupled with a growing number of accidents will boost the number of lumbar spinal fusion cases.
3. Rising adoption of minimally invasive surgery. With the growing popularity of MIS, many vendors are introducing innovative technology. Patients are demanding treatments that offer quicker recoveries.